Adaptive Biotechnologies Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VIKING GLOBAL INVESTORS LP | 05/15/2025 | 29.99 M | $222.85 M | 0.00% | 20.10% |
RUBRIC CAPITAL MANAGEMENT LP | 05/14/2025 | 13.12 M | $97.47 M | -10.15% | 8.79% |
BLACKROCK, INC. | 05/02/2025 | 12.23 M | $90.87 M | 0.90% | 8.20% |
VANGUARD GROUP INC | 05/09/2025 | 11.14 M | $82.80 M | 4.00% | 7.47% |
ARK INVESTMENT MANAGEMENT LLC | 05/07/2025 | 7.73 M | $57.45 M | -17.95% | 5.18% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 6.64 M | $49.35 M | 801.63% | 4.45% |
SUMITOMO MITSUI TRUST HOLDINGS, INC. | 04/25/2025 | 6.09 M | $45.22 M | -10.94% | 4.08% |
NIKKO ASSET MANAGEMENT AMERICAS, INC. | 05/07/2025 | 6.09 M | $45.16 M | -10.94% | 4.08% |
BRAIDWELL LP | 05/15/2025 | 4.80 M | $35.69 M | 100.00% | 3.22% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 3.00 M | $22.26 M | -52.40% | 2.01% |
ARISTOTLE ATLANTIC PARTNERS, LLC | 05/15/2025 | 2.94 M | $21.85 M | 1.89% | 1.97% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.78 M | $20.67 M | 3.59% | 1.86% |
STATE STREET CORP | 05/15/2025 | 2.69 M | $19.98 M | -1.48% | 1.80% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 05/02/2025 | 2.31 M | $17.14 M | -31.58% | 1.55% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.15 M | $15.99 M | 154.36% | 1.44% |
BLUE WATER LIFE SCIENCE ADVISORS, LP | 05/15/2025 | 2.15 M | $15.94 M | 0.00% | 1.44% |
VOYA INVESTMENT MANAGEMENT LLC | 06/18/2025 | 2.01 M | $14.90 M | -17.41% | 1.34% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 2.01 M | $14.90 M | -10.40% | 1.34% |
VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 1.76 M | $13.11 M | 9,892.22% | 1.18% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.47 M | $10.93 M | 510.61% | 0.99% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 1.42 M | $10.59 M | -11.23% | 0.95% |
05/12/2025 | 1.30 M | $9.62 M | 100.00% | 0.87% | |
KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 1.27 M | $9.43 M | 100.00% | 0.85% |
ABRDN PLC | 05/13/2025 | 1.20 M | $8.90 M | 19.28% | 0.80% |
MORGAN STANLEY | 05/15/2025 | 1.13 M | $8.36 M | -5.74% | 0.75% |
PIER CAPITAL, LLC | 05/13/2025 | 1.10 M | $8.15 M | -13.88% | 0.74% |
JPMORGAN CHASE & CO | 05/12/2025 | 1.08 M | $8.06 M | 64.47% | 0.73% |
NORTHERN TRUST CORP | 05/13/2025 | 1.05 M | $7.83 M | -3.69% | 0.71% |
LORD, ABBETT & CO. LLC | 05/13/2025 | 1.03 M | $7.63 M | 100.00% | 0.69% |
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 930.97 K | $6.92 M | 100.00% | 0.62% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 922.74 K | $6.86 M | -3.54% | 0.62% |
PRUDENTIAL FINANCIAL INC | 05/13/2025 | 637.99 K | $4.74 M | 32.37% | 0.43% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 05/07/2025 | 621.71 K | $4.62 M | -0.66% | 0.42% |
DEUTSCHE BANK AG\ | 05/09/2025 | 618.18 K | $4.59 M | -1.97% | 0.41% |
05/15/2025 | 611.64 K | $4.54 M | 100.00% | 0.41% | |
CLEARLINE CAPITAL LP | 05/16/2025 | 586.38 K | $4.36 M | -0.07% | 0.39% |
INVESCO LTD. | 05/12/2025 | 552.53 K | $4.11 M | 218.29% | 0.37% |
POLAR ASSET MANAGEMENT PARTNERS INC. | 05/15/2025 | 527.96 K | $3.92 M | 100.00% | 0.35% |
TUDOR INVESTMENT CORP ET AL | 05/15/2025 | 514.16 K | $3.82 M | 12.14% | 0.34% |
CERITY PARTNERS LLC | 04/30/2025 | 457.02 K | $3.40 M | -4.48% | 0.31% |
CINCTIVE CAPITAL MANAGEMENT LP | 05/15/2025 | 376.74 K | $2.80 M | 56.12% | 0.25% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 358.07 K | $2.66 M | -1.60% | 0.24% |
PDT PARTNERS, LLC | 05/15/2025 | 344.98 K | $2.56 M | 9.07% | 0.23% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 310.27 K | $2.26 M | 45.79% | 0.21% |
FMR LLC | 05/12/2025 | 288.47 K | $2.14 M | 12.80% | 0.19% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 285.14 K | $2.12 M | 98.78% | 0.19% |
TREXQUANT INVESTMENT LP | 05/14/2025 | 284.78 K | $2.12 M | 53.22% | 0.19% |
UBS GROUP AG | 05/13/2025 | 275.62 K | $2.05 M | -30.62% | 0.18% |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 205.19 K | $1.52 M | 88.89% | 0.14% |
BARCLAYS PLC | 05/15/2025 | 203.97 K | $1.52 M | -23.34% | 0.14% |
Adaptive Biotechnologies Corporation institutional Ownership - FAQ's
During the previous two years, 276 institutional investors and hedge funds held shares of Adaptive Biotechnologies Corporation. The most heavily invested institutionals were:
Rise Advisors, LLC: 0
VIKING GLOBAL INVESTORS LP: 29.99 M
Rubric Capital Management LP: 13.12 M
BlackRock, Inc.: 12.23 M
VANGUARD GROUP INC: 11.14 M
ARK Investment Management LLC: 7.73 M
101.07% of Adaptive Biotechnologies Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 165.85 M shares in the last 24 months. This purchase volume represents approximately $1.97 B in transactions.